get resolved, renaud? in many . get resolved, renaud? in many respects ending the rights is perhaps the easier part of the weather changes and it rains people stay at home, even of police are deployed at the writers are suppressed and enough stay at home, if enough people are arrested people lose the impetus to riot but the societal contempt that has built up for many years, that s a far harder to unpick and like you say, many of these regions have had significant investment in that seemingly hasn t been enough. investment in that seemingly hasn t been enough- investment in that seemingly hasn t been enough. yes, so, you could say at first that been enough. yes, so, you could say at first that there been enough. yes, so, you could say at first that there is been enough. yes, so, you could say at first that there is lawlessness - at first that there is lawlessness and drug trafficking in marseille, lyon, paris, the north and rotterdam, whatever. the drugs route, if you like. and
expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy, is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050.
Key suggestions from the report:
In 2020, anti-VEGF agents dominated the market owing to high preference by ophthalmologists, enhanced tissue penetration, and rapid responsive rates